trial · primary record
exemestane
Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2019-06-26 |
| Primary endpoint | Progression-free Survival |
| Registry ID | NCT00810797 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:36.059Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00810797
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- EXEMESTANE · approval
- Exemestane · compound